Regenerex Pharma (RGPX) Depreciation and Depletion (2018 - 2025)

Regenerex Pharma (RGPX) has 8 years of Depreciation and Depletion data on file, last reported at $1157.0 in Q3 2025.

• Depreciation and Depletion for Q3 2025 came in at $1157.0, up 37.57% year-over-year; the trailing twelve-month figure through Sep 2025 was $3485.0 (down 18.73% YoY), and the FY2025 annual result was $3054.0, down 28.61% from the prior year.
• Depreciation and Depletion declined to $1157.0 in Q3 2025 per RGPX's latest filing, from $1259.0 in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $1259.0 in Q2 2025 and troughed at $426.0 in Q1 2025.
• A 5-year average of $927.61 and a median of $928.0 in 2021 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2021 and 2022: Depreciation and Depletion sank 72.83% in 2021, then soared 115.49% in 2022.
• A 5-year view of Depreciation and Depletion shows it stood at $1015.0 in 2021, then retreated by 20.79% to $804.0 in 2022, then soared by 44.03% to $1158.0 in 2023, then tumbled by 44.47% to $643.0 in 2024, then jumped by 79.94% to $1157.0 in 2025.
• Business Quant data shows RGPX's Depreciation and Depletion at $1157.0 in Q3 2025, $1259.0 in Q2 2025, and $426.0 in Q1 2025.